Enantiomerically pure azepanes are sought after building blocks being widely used in the pharmaceutical industry. In the context of an RSV inhibitor drug discovery project, a joint  Janssen-NovAliX team have developed an efficient synthesis of racemic 2-methylazepane. Enantiomerically pure (R)-isomer was conveniently resolved by chiral SFC in development scale quantities. The successful outcome involved teamwork between in-sourced NovAliX chemists located Val-de-Reuil and out-sourced chemists in Illkirch. The resulting a publication showcases the complementary nature of our business models as well as the cohesion and efficiency of NovAliX teams working across different geographic locations.      

Access to full article

This website uses cookies to improve user experience